| 6.4 |
19.1 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 3.5 |
10.4 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 3.3 |
9.9 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 2.0 |
11.8 |
GO:0061365 |
positive regulation of triglyceride lipase activity(GO:0061365) |
| 2.0 |
3.9 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 1.9 |
5.6 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 1.8 |
7.3 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 1.7 |
5.0 |
GO:0007521 |
muscle cell fate determination(GO:0007521) mammary placode formation(GO:0060596) |
| 1.6 |
4.7 |
GO:1903903 |
striated muscle atrophy(GO:0014891) positive regulation of keratinocyte apoptotic process(GO:1902174) regulation of establishment of T cell polarity(GO:1903903) |
| 1.4 |
6.8 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 1.4 |
6.8 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 1.3 |
9.4 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 1.3 |
13.4 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 1.3 |
5.3 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 1.3 |
3.8 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 1.2 |
8.2 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.1 |
3.4 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 1.0 |
4.1 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 1.0 |
12.3 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 1.0 |
17.8 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.9 |
6.4 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.7 |
2.1 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.7 |
3.5 |
GO:1900085 |
negative regulation of pinocytosis(GO:0048550) negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) |
| 0.6 |
3.8 |
GO:0009169 |
purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.6 |
2.8 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.5 |
3.7 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.5 |
2.6 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.5 |
3.6 |
GO:0015840 |
urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.5 |
2.1 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.5 |
2.5 |
GO:2001170 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.5 |
2.5 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.5 |
1.5 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.4 |
3.1 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.4 |
1.3 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.4 |
3.9 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.4 |
3.6 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.4 |
1.2 |
GO:0046671 |
regulation of cellular pH reduction(GO:0032847) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.4 |
1.8 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.3 |
0.7 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.3 |
1.7 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.3 |
3.3 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.3 |
2.3 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.3 |
2.0 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.3 |
1.0 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.3 |
1.0 |
GO:0001803 |
type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) serotonin secretion by platelet(GO:0002554) |
| 0.3 |
1.5 |
GO:0019659 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.3 |
2.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 |
7.2 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.3 |
0.8 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.3 |
1.5 |
GO:0007135 |
meiosis II(GO:0007135) regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.3 |
0.8 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 |
2.3 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.2 |
4.2 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.2 |
1.2 |
GO:2000645 |
negative regulation of receptor catabolic process(GO:2000645) |
| 0.2 |
0.7 |
GO:2000977 |
oculomotor nerve development(GO:0021557) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) regulation of forebrain neuron differentiation(GO:2000977) |
| 0.2 |
1.2 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.2 |
0.9 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.2 |
2.4 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.9 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.2 |
0.8 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.2 |
4.5 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.2 |
1.0 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
2.2 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 |
0.6 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.2 |
2.6 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.2 |
0.7 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 |
4.4 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) |
| 0.2 |
2.9 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.2 |
4.8 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.2 |
2.8 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.2 |
0.7 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 |
2.1 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.2 |
0.5 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
0.6 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
2.3 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.1 |
4.8 |
GO:0009395 |
phospholipid catabolic process(GO:0009395) |
| 0.1 |
0.7 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
2.8 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.8 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.1 |
1.3 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
1.3 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
0.6 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.1 |
12.7 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.1 |
0.8 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.5 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.1 |
0.6 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) negative regulation of transcription by competitive promoter binding(GO:0010944) progesterone receptor signaling pathway(GO:0050847) |
| 0.1 |
0.3 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) ureteric bud formation(GO:0060676) |
| 0.1 |
1.4 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
2.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.4 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.1 |
0.5 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.1 |
0.9 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.1 |
0.4 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.1 |
2.5 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 |
5.0 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.1 |
0.4 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.1 |
2.4 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
0.6 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 |
1.8 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.1 |
1.1 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.1 |
2.3 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.1 |
0.3 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.1 |
4.4 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.1 |
4.8 |
GO:0043525 |
positive regulation of neuron apoptotic process(GO:0043525) |
| 0.1 |
2.0 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 |
0.6 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 0.1 |
1.0 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 |
1.6 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.1 |
0.2 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
0.9 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.5 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.1 |
2.3 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
0.8 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.1 |
0.4 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.1 |
0.3 |
GO:1900748 |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 |
0.3 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
0.5 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.1 |
0.7 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
3.0 |
GO:0051489 |
regulation of filopodium assembly(GO:0051489) |
| 0.1 |
1.1 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.1 |
1.2 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 |
0.3 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.1 |
0.9 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.1 |
2.4 |
GO:0046326 |
positive regulation of glucose import(GO:0046326) |
| 0.0 |
0.6 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.0 |
1.8 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.8 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.0 |
0.1 |
GO:0001907 |
killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.0 |
0.3 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
1.6 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.0 |
2.5 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.0 |
1.0 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.0 |
0.2 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.0 |
0.8 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
4.0 |
GO:0007160 |
cell-matrix adhesion(GO:0007160) |
| 0.0 |
0.5 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 |
0.3 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
0.2 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.2 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.0 |
0.6 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.0 |
0.2 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.7 |
GO:0046470 |
phosphatidylcholine metabolic process(GO:0046470) |
| 0.0 |
0.7 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.6 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
1.5 |
GO:0006633 |
fatty acid biosynthetic process(GO:0006633) |
| 0.0 |
0.4 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.0 |
0.2 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.0 |
0.7 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.4 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.0 |
0.7 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.0 |
1.7 |
GO:0007067 |
mitotic nuclear division(GO:0007067) |
| 0.0 |
1.2 |
GO:0048754 |
branching morphogenesis of an epithelial tube(GO:0048754) |
